Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts.

NCT06821594 is registered in ClinicalTrials.gov with Jinnah Postgraduate Medical Centre as lead sponsor.

NCT NCT06821594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06821594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts.
Lead sponsor
Jinnah Postgraduate Medical Centre
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
April 1, 2025
Completion date
September 30, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous warts